Abacavir, dolutegravir, and lamivudine and Risankizumab-rzaa topical
Determining the interaction of Abacavir, dolutegravir, and lamivudine and Risankizumab-rzaa topical and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: abacavir / dolutegravir / lamivudine
Brand name: Triumeq
Synonyms: Abacavir, Dolutegravir, and Lamivudine
Generic Name: risankizumab
Brand name: Skyrizi
Synonyms: Risankizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abacavir, dolutegravir, and lamivudine-Risedronate
- Abacavir, dolutegravir, and lamivudine-Risedronate and Calcium
- Abacavir, dolutegravir, and lamivudine-Risedronate Delayed Release
- Abacavir, dolutegravir, and lamivudine-Risedronate Delayed-Release Tablets
- Abacavir, dolutegravir, and lamivudine-Risedronate Sodium
- Abacavir, dolutegravir, and lamivudine-Risedronate Tablets
- Risankizumab-rzaa topical-Abacavir, Lamivudine and Zidovudine Tablets
- Risankizumab-rzaa topical-Abacavir, lamivudine, and zidovudine
- Risankizumab-rzaa topical-Abaloparatide
- Risankizumab-rzaa topical-Abaloparatide Subcutaneous
- Risankizumab-rzaa topical-Abatacept
- Risankizumab-rzaa topical-Abatacept Auto-Injectors